课题基金 / 基金详情

PRECARE is an innovative and integrated platform designed to improve the developmental surveillance of the baby.

PRECARE is an innovative and integrated platform designed to improve the developmental surveillance of the baby.
PRECARE 是一个创新的集成平台,旨在改善婴儿的发育监测。
批准号:
10603833
负责人:
Tony Xuyen Ma
金额:
$38.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-20 至 2024-08-31

项目摘要

项目成果

Tony Xuyen Ma的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary In the US, over 63% of babies do not receive developmental surveillance. Furthermore, despite increased developmental surveillance, 10% or less of babies with developmental delays (DD) (approximately 140,000) are being correctly identified and receive the early intervention (EI) they need. Developmental surveillance can identify developmental delays (DD) to support early interventions (EI) to minimize the impacts of the delays. However, only half of the physicians use a formal screening tool, with most reviewing developmental milestones and prompting parents for developmental concerns. Physicians have limited data points (i.e., a baby’s developmental history) with a small window to complete a comprehensive risk assessment at each clinical visit. Relying on parents is also a challenge. Parents face barriers, such as lack of knowledge about child development, reliable recollection of developmental events during the visit, and longitudinal tracking of developmental milestones, leaving them ill-equipped to observe and raise concerns properly. To address the barriers, we propose to develop a Platform to Recognize and Evaluate Children for Age- Appropriate Response and Early Detection of Delays (PRECARE). PRECARE will provide an innovative and integrated solution to developmental surveillance by leveraging education and technologies that support smart motion detection and convenient data sharing. Specifically, PRECARE will include (1) microlearning modules for parents, including early indicators of DD and instructions on how to assess early motor abilities predictive of DD to prepare parents for well-child visits; (2) multi-purpose developmental monitoring system for automatic, ubiquitous, and smart motion detection; (3) computer vision and machine learning algorithms to quantify behavioral data; and (4) case management system that allows pediatricians to access easy-to-read dashboards of a baby’s behavioral data for risk assessment. PRECARE will be designed and developed by a transdisciplinary team led by Mr. Tony Ma (PI), in coordination with Co-Investigators (Co-I), Dr. Michele Lobo, Associate Professor from the University of Delaware, and Dr. Shishir Shah, Professor and Chair of Department of Computer Science at University of Houston. The specific aims of this SBIR Phase 1 are: 1) Use formative research with parents with babies and pediatricians to develop the prototype PRECARE platform. 2) Pilot test PRECARE with 20 parents with babies and their pediatricians to evaluate the platform’s feasibility (i.e., usability and acceptance). In the short term, the study will demonstrate the feasibility of a secure, cloud-based platform to provide education, mediate parent-provider information sharing and communication, and flag early indicators of DD. In the long-term, PRECARE will increase developmental surveillance and EI, enable the creation of normative databases for novel behavior makers of DD, and improve current surveillance protocols.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-modal Intervention for Lactation Care (MILC) will be a mHealth platform to increase
  • 批准号:
    10401171
  • 项目类别:
  • 资助金额:
    $31.35万
  • 财政年份:
    2021
  • 负责人:
    Tony Xuyen Ma
  • 依托单位:
WE-CARE - an innovative platform ofWomen Engaged in Comprehensive Addiction and Recovery Environments for SubstanceUse Women
  • 批准号:
    10323630
  • 项目类别:
  • 资助金额:
    $33.21万
  • 财政年份:
    2021
  • 负责人:
    Tony Xuyen Ma
  • 依托单位:
Kukua - an innovative, fun, and engaging, early childhood STEM platform as a promotion intervention program for age 4-8 years old AA girls
  • 批准号:
    10255019
  • 项目类别:
  • 资助金额:
    $39.35万
  • 财政年份:
    2021
  • 负责人:
    Tony Xuyen Ma
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: